Guggenheim Capital’s Apollo Endosurgery, Inc. APEN Stock Holding History

Guggenheim Capital’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-301	Closed	-$4K	–	2948
2016 Q1	$4K	Buy	301 +135	+81%	+$1.88K	﹤0.01%	2897
2015 Q4	$3K	Hold	166	–	–	﹤0.01%	2977
2015 Q3	$3K	Buy	+166	New	+$3.16K	﹤0.01%	2950

Other funds holding APEN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SBIA

Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Guggenheim Capital's APEN Position: Q2 2016 in Review

Guggenheim Capital sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2016, closing a stake of 301 shares — an estimated $4K sold.

Guggenheim Capital first reported a position in APEN in Q3 2015 and held it in 3 quarters. The position peaked at $4K in Q1 2016. 11 funds tracked by Wall St. Rank hold APEN as of Q2 2016.

Guggenheim Capital reported no remaining Apollo Endosurgery, Inc. position as of Q2 2016 after selling out during the quarter.
Guggenheim Capital sold 301 Apollo Endosurgery, Inc. shares in Q2 2016, an estimated $4K.
Guggenheim Capital first reported a position in Apollo Endosurgery, Inc. in Q3 2015 and held it in 3 quarters.
Guggenheim Capital's Apollo Endosurgery, Inc. position peaked at $4K in Q1 2016.
11 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2016.

Based on Guggenheim Capital's 13F filing for Q2 2016, filed 15 Aug 2016.